ILY-105-A

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameILY-105-A
Drug Alias Namesecond generation potassium binder (Relypsa)RLY-105-AILY-105-A
ClassificationSmall molecules
Mechanisms of ActionPotassium channel modulators
TargetsPotassium channel
Therapy Area/IndicationsHyperkalemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRelypsa Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRelypsa Inc
Active IndicationsN/A
Inactive IndicationsHyperkalemia

Other Information

ATC CodeN/A
Related LinksN/A